Inhibition of replication of drug-resistant HIV type 1 isolates by polypurine tract-specific oligodeoxynucleotide TFO AJENDIS, J; STRACK, B; MOELLING, K et al.AIDS research and human retroviruses. 1998, Vol 14, Num 11, pp 999-1005, issn 0889-2229Article

Inhibition of replication of fresh HIV type 1 patient isolates by a polypurine tract-specific self-complementary oligodeoxynucleotideJENDIS, J; STRACK, B; VOLKMANN, S et al.AIDS research and human retroviruses. 1996, Vol 12, Num 12, pp 1161-1168, issn 0889-2229Article

Isolation of an in vitro transmissible agent with reverse transcriptase activity from a blood donor with a borderline-positive HIV-1 serology for more than five yearsSCHÜPBACH, J; PYRA, H; JENDIS, J et al.Clinical and diagnostic virology. 1996, Vol 5, Num 2-3, pp 197-203, issn 0928-0197Conference Paper

IgG, IgM, and IgA response to HIV in infants born to HIV-1 infected mothersSCHÜPBACH, J; TOMASIK, Z; JENDIS, J et al.Journal of acquired immune deficiency syndromes. 1994, Vol 7, Num 5, pp 421-427, issn 0894-9255Article

Immunological evaluation in the early diagnosis of prenatal or perinatal HIV infectionNADAL, D; HUNZIKER, U. A; SCHÜPBACH, J et al.Archives of disease in childhood. 1989, Vol 64, Num 5, pp 662-669, issn 0003-9888Article

Stable human immunodeficiency virus encephalopathy in two infants receiving early intravenous gammaglobulin plus antimicrobial prophylaxisHUNZIKER, U. A; NADAL, D; JENDIS, J. B et al.European journal of pediatrics. 1989, Vol 148, Num 5, pp 417-422, issn 0340-6199, 6 p.Article